ORKA-001, a novel half-life extended IL-23p19 monoclonal antibody (mAb), first-in-human dosing now expected first quarter 2025 ORKA-002, a novel half-life extended IL-17A/F mAb, first-in-human dosing ...
Have you ever spent hours crafting a timeline chart, only to abandon it because it was too clunky, rigid, or just plain uninspiring? You’re not alone. Many tools promise sleek visuals but fall short ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback